Zygomycosis is a serious fungal infection. It's caused by certain types of fungi that can infect different parts of the body, like the sinuses or lungs. It's important to see a doctor if you suspect this infection.
Every report comes from a Lived member, sent anonymously.
Have you tried Amphotericin B for Zygomycosis?
Zygomycosis is an older name for infections caused by a group of molds once classified together as zygomycetes. Today doctors mostly use the term interchangeably with mucormycosis, a rare but serious infection caused by molds such as Rhizopus and Mucor. These molds live in soil, decaying plants and spoiled food, and people breathe in their spores all the time. They cause illness mainly when the body's defenses are weakened or when spores get into broken skin. Mucormycosis is dangerous because the mold grows into blood vessels, cutting off blood supply so that tissue dies. It most often starts in the sinuses and can spread to the eye and brain (rhino-orbito-cerebral disease). It can also affect the lungs, the skin after an injury, the digestive tract, or spread through the body. It can progress over days. The old umbrella term also covered entomophthoromycosis (also spelled entomophthoramycosis), a different, slow infection seen mostly in tropical regions in people with healthy immune systems. It usually causes firm swelling under the skin of the face or limbs, or a mass in the bowel, and develops over months. Phycomycosis is an even older name for the same group of infections.
Mucormycosis is caused by contact with molds that are everywhere in the environment, so the main question is not exposure but whether the body can fight them off. The strongest risk factor worldwide is diabetes that is poorly controlled, especially diabetic ketoacidosis, a dangerous buildup of acids in the blood when insulin is lacking. High blood sugar and acidity weaken the white blood cells that normally clear fungal spores. Other major risk groups are people with blood cancers, people with very low white blood cell counts after chemotherapy, organ or stem cell transplant recipients, and people taking corticosteroids such as prednisone or other drugs that suppress the immune system. Recent COVID-19 infection has also been linked to mucormycosis. Iron overload and the iron-removing drug deferoxamine also raise risk. People with healthy immune systems can develop mucormycosis of the skin and soft tissue after deep wounds, such as those from car crashes, natural disasters, burns or surgery, when soil or debris gets into the wound. Entomophthoromycosis is thought to start from breathing in spores or from minor skin injuries in tropical areas, and it is not tied to a weakened immune system.
Diagnosis starts with recognizing the pattern: a person in a risk group with sinus or facial pain, swelling on one side of the face, a dark patch inside the nose or mouth, eye symptoms, or a lung infection that is not improving on antibiotics. Because the infection moves fast, doctors begin testing and often treatment at the same time. Imaging shows how far the infection has spread. A CT scan or MRI of the sinuses and head looks for sinus disease and bone damage, and MRI is preferred when the eye or brain may be involved. A chest CT is used when the lungs are suspected. For sinus disease, a specialist usually looks inside the nose with a thin camera (endoscopy). The diagnosis is confirmed with a biopsy, a small sample of affected tissue examined under a microscope for the characteristic broad, ribbon-like fungal threads invading tissue. Culture and genetic tests on the sample identify the specific mold. Mucormycosis can look similar to aspergillosis, another mold infection, under the microscope, and the distinction matters because some common antifungal drugs do not work against these molds. Entomophthoromycosis is also diagnosed by biopsy, which shows a long-standing inflammatory reaction; it can be mistaken for cancer or inflammatory bowel disease.
Mucormycosis needs urgent treatment in a hospital, ideally with a team of infectious disease specialists, surgeons and other experts. Treatment has three parts, and all three matter. The first is surgery to remove dead and infected tissue, because antifungal drugs cannot reach tissue that has lost its blood supply. Operations are often repeated as the infection is brought under control. For sinus and facial infection this can mean removing parts of the sinuses and nearby bone, and sometimes tissue around the eye. The second is antifungal medicine through a vein. The preferred first choice is high-dose liposomal amphotericin B (AmBisome), a long-standing antifungal in a fat-based form that is gentler on the kidneys than the original drug, though kidney function still needs close monitoring. Isavuconazole (Cresemba), a newer antifungal from the azole family that is FDA-approved for mucormycosis, and posaconazole, a related azole, are alternatives and are often used as pills to continue treatment after the infection stabilizes. Treatment usually lasts weeks to months. The third is correcting what allowed the infection to take hold: bringing blood sugar and ketoacidosis under control, and reducing steroids or other immune-suppressing drugs where possible. People who stay immune-suppressed after recovering may need to continue or restart antifungal medicine to keep the infection from returning. Entomophthoromycosis is treated differently, usually with weeks to months of itraconazole, an antifungal pill, sometimes combined with potassium iodide. Surgery is used for some bowel or skin infections.
Mucormycosis is a severe illness, and outcomes vary widely with the person's underlying health and where the infection is. Overall, between 40% and 80% of people with mucormycosis die from it or with it. Outcomes are better when the infection is limited to the sinuses or skin and is caught early, and worst when it has reached the brain or spread through the body, or when the person has a blood cancer or stem cell transplant. Recovery is often long. Hospital stays can last weeks, and antifungal treatment may continue at home for months with regular blood tests and scans to check progress. Surgery to remove infected tissue can leave lasting changes, such as loss of vision or changes to the face or mouth, and some people need further treatment and support afterward to help with daily activities and changes in appearance. The infection can return, especially if immune suppression continues, so follow-up with the specialist team continues after treatment ends. Entomophthoromycosis usually progresses slowly and is rarely fatal when confined to the skin or face, but swelling can be disfiguring if treatment is delayed. The bowel form is more serious. Relapse is possible, so follow-up often continues for months after the swelling resolves.
If you have diabetes, are being treated for cancer, have had a transplant or take steroids or other immune-suppressing medicines, contact your care team the same day about sinus pain or congestion with fever, a wound that is turning dark or spreading, or a cough, chest pain or shortness of breath with fever that is not improving. Mention that you are in a high-risk group. For anyone in these groups, swelling or pain on one side of the face, a black or dark patch inside the nose or on the roof of the mouth, eye pain, a bulging eye, a drooping eyelid, double vision or loss of vision, numbness of the face, coughing up blood, or new confusion is a medical emergency: go to an emergency department or call 911 right away, because delays in treatment cost lives. A firm, painless swelling of the face or a limb that keeps growing over weeks, especially after time in a tropical region, should be checked at a routine visit and may need a biopsy.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Zygomycosis is like, what's helped you, or ask the community a question.